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Purpose: Imaging of patient anatomy during treatment is a necessity for position verification and for
adaptive radiotherapy based on daily dose recalculation. Ultrasound (US) image guided radiotherapy
systems are currently available to collect US images at the simulation stage (USsim), coregistered
with the simulation computed tomography (CT), and during all treatment fractions. The authors
hypothesize that a deformation field derived from US-based deformable image registration can be
used to create a daily pseudo-CT (CTps) image that is more representative of the patients’ geometry
during treatment than the CT acquired at simulation stage (CTsim).
Methods: The three prostate patients, considered to evaluate this hypothesis, had coregistered CT
and US scans on various days. In particular, two patients had two US–CT datasets each and the third
one had five US–CT datasets. Deformation fields were computed between pairs of US images of
the same patient and then applied to the corresponding USsim scan to yield a new deformed CTps
scan. The original treatment plans were used to recalculate dose distributions in the simulation,
deformed and ground truth CT (CTgt) images to compare dice similarity coefficients, maximum
absolute distance, and mean absolute distance on CT delineations and gamma index (γ) evaluations
on both the Hounsfield units (HUs) and the dose.
Results: In the majority, deformation did improve the results for all three evaluation methods. The
change in gamma failure for dose (γDose, 3%, 3 mm) ranged from an improvement of 11.2% in the
prostate volume to a deterioration of 1.3% in the prostate and bladder. The change in gamma failure
for the CT images (γCT, 50 HU, 3 mm) ranged from an improvement of 20.5% in the anus and rectum
to a deterioration of 3.2% in the prostate.
Conclusions: This new technique may generate CTps images that are more representative of the
actual patient anatomy than the CTsim scan. C 2016 American Association of Physicists in Medicine.
[http://dx.doi.org/10.1118/1.4944064]
Key words: ultrasound imaging, image guided radiotherapy, deformable image registration, adaptive
radiotherapy, prostate cancer
1. INTRODUCTION
Image guidance has become an essential part of radiotherapy
(RT) treatment to allow for safe delivery of radiation doses.
Image guided RT (IGRT) is often performed for several or all
treatment fractions to position the patient correctly. Beyond
the aim of image guidance, the availability of daily imaging
also allows for the possibility of adaptive RT (ART).1,2 The
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goal of ART is to improve RT treatment by systematically
monitoring dose discrepancies and incorporating them to
reoptimize the treatment plan. Normally only the planning
computed tomography (CT) image, acquired at simulation
stage, is available for the dose calculation, but both interfrac-
tion and intrafraction patient anatomy motion and changes
(like tumor shrinkage, nodal volume changes, andweight loss)
may alter the dose distribution.3–6 In ART, the anatomy from
the planning CT is updated by the anatomy from the daily
imaging, acquired during the IGRT workflow to monitor dose
distribution and if necessary adapt the treatment plan.
CT scanners are usually not available in the treatment room.
Instead, cone-beam computed tomography (CBCT) can be
used for dose calculations either directly7–10 or indirectly with
deformable image registration (DIR)11,12 even though they
offer a lower image quality when compared to CT scanners. In
some studies, using the CBCT directly for dose calculations,
the inaccuracies in the Hounsfield units (HUs) are large
enough to result in clinically relevant dose errors.13–15
In this paper, a workflow is introduced to produce pseudo-
CT images based on deformable registration of ultrasound
(US) volumes. A 3DUS IGRT system can acquire volumetric,
high-contrast soft-tissue images noninvasively on a daily
basis without using ionizing radiation (Fig. 1). Subsequently,
deformable registration of these volumes can reveal changes
in tissue distribution that occurred over time.
Relatively few papers on US to US deformable registration
can be found in the literature and as far as we could find, there
are presently no papers involving deformable registration of
pelvic or abdominal US volumes in RT. In other medical
fields, however, some publications are available. For example,
Shekhar et al.16 proposed a nonrigid method based on mutual
information to register cardiac US images in different phases
throughout the complete cardiac cycle.
A similar workflow as proposed in this study was presented
for brain surgery applications by Pennec et al.17 In this study,
preoperativemagnetic resonance (MR) images andUS images
were acquired. Subsequently, intraoperative US images were
used to create pseudo-MR images of the brain. This resulted
in acceptable representations of the brain anatomy during
surgery.
As these results were promising, we used a similar
approach to create pseudo-CT (CTps) images. We hypothesize
that a pseudo-CT image can be created based on CTsim using
a deformation field calculated between USsim and UStx. We
expect that the CTps so created gives a better representation
of the patient’s anatomy during treatment delivery than the
planning CTsim.
2. MATERIALS AND METHODS
2.A. The concept
In the proposed workflow (Fig. 2) for CTps image creation,
DIR has to be performed to calculate a deformation field
between USsim and UStx. Subsequently, this deformation field
has to be applied to CTsimwhich results in the creation of CTps.
2.B. Patient scans
Clinical examples with multiple coregistered US–CT
combinations at the simulation stage (instead of the treatment
stage) were used to validate the concept. In this study, three
prostate cancer patients from a previous study18 were used.
Due to clinical reasons, these patients underwent additionalUS
and CT imaging next to USsim and CTsim acquisitions. In the
normal clinicalworkflow, these extraCTandUS images arenot
acquired. The extra CT scans were used as ground truth (CTgt)
scans to which the derived CTps scans can be compared in this
proof of concept study. In Table I, the method used to calculate
and evaluate the result from the deformations is described.
The coregistered CT–US images were acquired at two
time points for patients 1 and 2 (three and one weeks apart,
respectively). Acquisitions for patient 3 were made for five
time points where the first two were two weeks apart and the
following three time points were one week apart.
F. 1. Workflow of acquisition of CTsim, USsim, and UStx images (Clarity US system; Elekta) (adapted from Elekta with their permission).
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F. 2. DIR is computed between the two US images (USsim and UStx) and then applied to CTsim; a new pseudo-CTps is obtained. The question is whether this
CTps is indeed representative for the patient anatomy during treatment.
All coregistered US–CT combinations were acquired in the
CT-room with the patient’s external skin markers positioned
along the room lasers. The 3D US scans (Clarity system;
Elekta, Stockholm, Sweden, voxels: 1× 1 mm2× 3 mm slice
thickness; US probe type C5-2/60, center frequency 3.5 MHz,
Sonix Series; Ultrasonix Medical Corporation, Richmond,
BC, Canada) were performed transabdominally immediately
before or after the CT scan. The number of voxels of the US
images varied between [512, 512, 90] and [512, 512, 131].
For each patient, the images were resampled to match the
dimensions of the first acquired US volume (USsim).
The CT scans were acquired using a SOMATOM Sensa-
tion Open (Syngo CT 2006A, Siemens, Germany; voxels:
1× 1 mm2× 3 mm slice thickness). Both scans were per-
formed in the same supine patient position, stabilized with
knee fix and foot support (Combifix, CivcoMedical Solutions,
Kalona, IA, USA), resulting in a correct automatic fusion of
the US and CT images.19
In all US images, the prostate was delineated. All CT
images had delineations of the body contour, prostate, seminal
vesiculae (SV, except for patient 3), anus, rectum, and bladder
(except for patient 1).
2.C. Deformation
For eachUS–CTcombination (as detailed inTable I), defor-
mation fields were calculated using a DIR algorithm (B-spline
T I. Overview of the US–CT combinations used to calculate and evaluate
US-based deformable image registration. Patient 3 sets A–D differ in the










1 US1 US2 CT1 CT2
2 US1 US2 CT1 CT2
3 A US1 US2 CT1 CT2
3 B US1 US3 CT1 CT3
3 C US1 US4 CT1 CT4
3 D US1 US5 CT1 CT5
Note: CT, computed tomography; CTgt, ground truth CT acquired at the same time
as the US image used as UStx; CTsim, reference/planning CT, acquired at the time
of simulation; GT, ground truth; US, ultrasound; USsim, reference/planning US,
acquired at the time of CT simulation; and UStx, US images daily acquired at the
treatment stage.
method from ElastiX; Utrecht, The Netherlands).20,21 Prior
to the deformation field calculation, all volumes were resam-
pled to the same image dimensions per patient. In addition,
segmentation of the CTsim images resulted in a binary mask
of the bones and the region of interest (ROI) was defined as
the overlapping parts of the US images (ROI: USsim∩UStx).
All these preprocessing steps were performed in the 
(MathWorks, Inc., Natick, MA) software.
During the acquisition of the different US–CT combi-
nations, the patients were in the same position with the
body markers aligned to the lasers. For this reason, no
rigid transformation was performed prior to the deformable
registration, in particular, to prevent erroneous full body shifts
based on internal shifts of the prostate.22
As mentioned before, the deformable registration was
performed using the ElastiX software. This software package
requires three inputs: fixed image (UStx), moving image
(USsim), and a parameter file. The parameter file contains
all the parameters that determine the characteristics of the
registration. In Sec. A of the supplementary material,23 an
example of such a parameter file is detailed.
In this study, the deformable registration was performed
either on the overlapping parts of the US images or on binary
masks of the delineated prostate volumes only. In total, five
different parameter sets (parameters A–E in Table II) were
defined for this purpose using the file in Sec. A of the
supplementary material23 as a basis.
The deformation field calculations were based on the
overlapping parts of the US images, but were propagated
further through the image (Fig. 3). Also bones were some-
times present in these overlapping parts. As bones are in
principle rigid structures, they are not expected to undergo
deformations. Therefore, the binary bone mask defined during
preprocessing was input in the rigidity penalty23 of ElastiX to
prevent bones from deforming.
2.D. Evaluation of the deformation
The created CTps and the deformed CT delineations were
then compared to the ground truth, i.e., the corresponding
CTgt and its delineations. The contours were evaluated using
the dice similarity coefficient [DSC= (2|X ∩Y |)/(|X |+ |Y |)].
A DSC ratio of 1 indicates complete overlap, while 0 indicates
no overlap.
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T II. Five different parameter sets (A–E) were used during the deformable registration. This registration
could be based on the whole US volume or on the binary mask of the delineated prostate volume only (reported
in the columns: fixed image and moving image). In addition, both the metric and iterations were varied among the
different sets.
Parameter set Fixed image Moving image Metric Iterations
A UStx USsim Normalized-correlation 10
B UStx USsim Normalized-correlation 50
C UStx USsim Normalized-correlation 100
D Prostate mask UStx Prostate mask USsim Mean-squares 100
E Prostate mask UStx Prostate mask USsim Mean-squares 300
Note: UStx, daily acquired US image at treatment stage. USsim, reference/planning US acquired at the time of CT
simulations.
In addition, the prostate contours were also evaluated using
both the maximum absolute distance (MAX) and the mean
absolute distance (MAD).24 The MAX defines the largest
difference between two contours, e.g., prostate contour A and
prostate contour B. For each point a on prostate contour A,
the minimal distance to all points on prostate contour B was
calculated. The same was repeated for each point b on prostate
contour B with respect to prostate contour A. This resulted in
a set of minimal distances and the maximum of this set is
referred to as MAX. Calculating the mean of this set gave the
MAD.
The CTsim and CTps images were compared to CTgt using
a gamma (γ) index evaluation.25,26 The γ index is commonly
used for dose evaluations. Prior to the index calculation, two
acceptance criteria need to be set: voxel-by-voxel numerical
dose difference and distance-to-agreement (DTA: distance
between a voxel on one volume and the nearest voxel in the
other volume that has the same dose). The resulting index
gives information on a voxel scale, while taking the voxels in
the vicinity into account as well.
In this case, not only dose was evaluated with the γ index
but also HU (γCT). The γ values were calculated using an in-
house developed method27,28 using  and ++. The used
method allows the sign of the γ value to indicate whether
an overdose (γ > 0) or underdose (γ < 0) is found for each
voxel.28 In this case, because we evaluate HU, a γ > 0 means
that the HU is relatively higher than the reference and γ < 0
means that theHU is relatively lower. A value |γ | > 1 in a voxel
indicates that the voxel fails to meet the acceptance criteria;
in this case, a 50 HU voxel intensity difference and a 3 mm
distance-to-agreement. (The 50 HU is a conservative measure
based on that for typical radiotherapy beams; to produce a
1% error in dosimetry would require errors of over 8% in
bone electron density29 and hence HU. The 3 mm distance-
to-agreement is a commonly used criterion in dosimetry.26)
The percentages of the volume with a |γCT| > 1 within
the contours “intersection body contours,” “prostate,” “anus
and rectum,” and “bladder” were reported. The percentages
of gamma failure and DSC evaluations are reported using the
contours of the CTgt, except for the intersection body contours
which is the overlapping part of the body contours of both
CTsim and CTgt.
2.E. Dose calculation and evaluation
Dose distributions were obtained by recalculating the
original treatment plans (five-beam IMRT plans; XiO CMS
4.51, Elekta, Stockholm, Sweden) designed on the planning
CTsim, on the CTsim, CTps, and CTgt scans. For this, an in-
house developed software was used, based on Monte Carlo
F. 3. Example of overlap between CT (gray) and US (color) (a) and between two US images (b) of patient 1. US-based DIR can only be performed on the
area where both CT and US information (of both USsim and UStx) is available. In this example, only the prostate and its surrounding tissue, e.g., a part of the
bladder, are present in both US images. In (c), only the overlapping area of both US images (yellow contour) contains information where the deformation field
(2D representation with red arrows) is based on. The field propagates further beyond this border (see color version online).
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simulation using the XVMC code.30,31 Dose distributions on
the CTsim and CTps images were compared to the dose on CTgt
using a γ evaluation (γDose),
25 with acceptance criteria of 3%
dose difference and 3 mm distance-to-agreement. Again the
percentage of the volume with a |γDose| > 1 within the contours
intersection body contours, prostate, anus and rectum, and
bladder was reported.
3. RESULTS
In most cases, deformation did improve the results accord-
ing to all evaluation methods, although these improvements
were in some cases very small or even negligible. Only for
patient 1, there was a large improvement (more than 10%
decrease in the volumewith |γDose| > 1) in the dose of the pros-
tate when the intensity based normalized-correlation metric
with 100 iterations (parameter set C) was used (Table III).
In Fig. 4, an example is given for patient 1 using parameter
set C. In the second column, the overlap of the prostate
and anus and rectum contours is shown. DSC increased by
0.3 when the deformations were used. The third and fourth
columns show the γCT and γDose values. In the overlapping
body contours, the percentage of γCT failure decreased by
1.7% in volume. For the prostate and anus and rectum
contours, there was a γCT failure decrease of 9% and 8.4%,
respectively. For the dose, the volume percentage of γdose
failure decreased by 11.2% in volume for the prostate. Yet
the percentage of γdose failure decreased by only 0.6% and
0.0% for the overlapping body contours and anus and rectum
contours, respectively.
All available results for patient 1 are summarized in
Fig. 5. Figure 5(A) shows that the DSC improved for all
parameter sets. For prostate, the best results were obtained
with parameter set E; for anus and rectum, set C performed
best. Both the MAD and the MAX where smaller compared
to the reference situation [Fig. 5(B)]. Figures 5(C) and 5(D)
detail results on gamma failure, respectively, based on CT
values and dose. In case of CT based evaluations, the best
results were achieved using parameter set B for prostate and
anus and rectum and using parameter set D for the body
contours. For the dose based evaluations, parameter set C
gave the best results in all cases. The analyses were repeated
for all available patient data and the overview of the results is
detailed in Fig. B of the supplementary material.23
Evaluation of all patient cases [Table III and Figs. B(A,E,I,
M,Q,U) in the supplementary material23] shows that the DSC
of the prostate increased the most for the two contour based
parameter sets (D and E). (Parameter set E with 300 iterations
did not succeed in the deformation of patient 2 because there
was a too small overlapping volume. Therefore not enough
voxels could be mapped and the registration failed to find
a solution.) Only for patient 3a, none of the parameter sets
gave an improvement for any of the contours. Overall, the
maximum changes in DSC for the intensity based normalized-
correlation parameter sets were a decrease of −0.5 or an
improvement of +0.3. For the contour based parameter sets,
these were −0.3 and +0.4.
T III. Five evaluation methods were used to evaluate the delineated
prostate contours. The first and second columns detail the patient and the used
evaluation method. Both gamma index values show the volume percentage of
gamma failure, [γCT(50 HU,3 mm) > 1] and [γDose(3%,3 mm) > 1], respectively.
In the third column, the reference situation (comparison between CTsim
and CTgt) can be found. In the final five columns, the results for each of
the parameter sets (A–E) are detailed. The bold numbers indicate which
parameter sets resulted in the same result or in an improvement with respect
to the reference.
Patient Metric Ref. A B C D E
1
DSC 0.4 0.7 0.7 0.7 0.7 0.7
MAD (mm) 7.5 3.3 3.5 3.7 2.7 2.7
MAX (mm) 27.9 15.3 16.3 16.0 9.8 12.2
γCT (%) 12.0 4.6 2.9 3.0 5.3 7.1
γDose (%) 18.3 12.4 8.1 7.1 13.0 13.7
2
DSC 0.5 0.5 0.5 0.5 0.6 —
MAD (mm) 5.1 5.5 5.5 5.7 3.9
MAX (mm) 16.0 18.1 21.6 23.2 13.9
γCT (%) 11.5 14.6 12.8 12.3 10.2 —
γDose (%) 1.6 2.2 2.8 2.9 1.4 —
3a
DSC 0.8 0.6 0.4 0.4 0.6 0.6
MAD (mm) 1.6 4.5 6.1 6.5 3.8 3.8
MAX (mm) 5.8 14.3 16.3 18.0 10.7 10.7
γCT (%) 6.9 7.4 7.8 8.5 7.5 7.3
γDose (%) 2.3 2.0 1.6 1.9 2.1 1.9
3b
DSC 0.8 0.6 0.6 0.6 0.8 0.8
MAD (mm) 2.3 4.3 4.2 4.4 2.1 2.3
MAX (mm) 8.4 16.4 18.9 19.1 5.9 6.1
γCT (%) 6.6 6.6 7.0 6.8 5.0 5.1
γDose (%) 3.8 3.5 2.7 3.2 1.8 2.2
3c
DSC 0.6 0.5 0.5 0.5 0.7 0.7
MAD (mm) 4.4 3.8 4.4 4.9 2.5 2.2
MAX (mm) 12.4 14.0 12.4 13.0 7.1 6.2
γCT (%) 9.9 7.1 7.7 7.2 7.9 6.8
γDose (%) 4.1 3.3 3.5 4.2 3.4 3.8
3d
DSC 0.4 0.5 0.6 0.7 0.8 0.8
MAD (mm) 6.6 5.9 4.5 4.0 2.1 1.9
MAX (mm) 20.1 22.0 25.7 27.5 10.4 9.7
γCT (%) 11.8 6.7 4.4 4.0 10.1 9.3
γDose (%) 10.3 9.9 9.5 8.7 6.9 6.5
Note: DSC, dice similarity coefficient; MAD, mean absolute distance; MAX,
maximum absolute distance; and γCT, γCT(50 HU,3 mm)>1; γDose, γDose(3%,3 mm)>1.
For the changes in CT HU values, the percentage of the
volume with a |γCT(50 HU,3 mm)| > 1 for prostate is shown in
Table III and for the other contours, in the supplementary
material [Table B and Figs. B(C,G,K,O,S,W)23]. A maximum
improvement was seen of 20.5% (14.6% for contour based)
and the poorest results gave an increase of 3.2% (2.2% for
contour based) in the volume with |γCT(50 HU,3 mm)| > 1.
Looking at the prostate results as shown in Table III, in
case an improvement was achieved, the contour parameter set
(D, 100 iterations) seemed to give an improvement in most
cases, yet it was not always the best one. The results for the
other contours (body, anus and rectum, and bladder) that can
be found in Table B in the supplementary material23 confirm
this as well.
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F. 4. Results for patient 1 (parameter set C). In the first column, the CTsim and CTps (in pink) are compared to CTgt (in green). In the second column, the
contours of prostate (P) and anus/rectum (A/R) are compared. When the images are grayscale (column 1) or white (column 2), there is overlap between the
compared images. The third and fourth columns show the γCT (column 3) and γDose (column 4). In green, the γ values are between −1 and 1. In red and blue
are the voxels in which the γ failed to meet the criteria of (50 HU, 3 mm) for the CT values and (3%, 3 mm) for the dose. For column 4, the areas where there is
an underdosages compared to CTgt (γDose < −1) are shown in blue. In red, there is an overdosage compared to CTgt (γDose > 1) (see color version online).
4. DISCUSSION
We have evaluated the impact of applying US-derived
tissue deformations to approximate CT images to the real
anatomical organ position of prostate patients during radiation
therapy. As noted before, a similar workflow was presented
by Pennec et al.17 for brain surgery applications. However, in
that study, pseudo-MR images of the brain were created. To
our knowledge, this is the first time a similar method is used
for RT applications.
In this study, patients 1 and 3d would have benefited most
from the deformations (>3% volume decrease for the volume
F. 5. Results for all five parameter sets used on patient 1. The circle represents the body contours, the star the prostate contours, and the square a combination of
anus and rectum. (A) DSC; (B) absolute distance for the prostate contours (MAX andMAD); (C) volume percentage of the gamma failure [|γCT(50 HU,3 mm)| > 1];
and (D) percentage of a gamma failure [|γDose(3%,3 mm)| > 1].
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with a |γDose| > 1). In addition, the difference in dose between
CTsim and CTgt was there also the largest (>10% volume with
a |γDose| > 1). For the other patient cases, the improvements
were not clinically relevant.
Ideally, one should be able to evaluate beforehand which
patients would benefit from applying the deformations. The
only metric that is available prior to DIR and could be suitable
is the DSC of the prostate contours onUSsim andUStx. A statis-
tical evaluation was performed to find a possible correlation
between these DSCs and the effect on the dose deposition
on the prostate (|γDose| > 1). Unfortunately such a correlation
was not found, possibly due to the limited number of patients.
However, there seems to be a trend that the patients with the
largest geometric changes benefit most from deformations, but
a future study with a larger image database will be necessary
to validate the predictive power of this DSC parameter to get
a clearer indication when it is worthwhile to perform DIR.
Besides a larger database to perform statistics, such a
database could be used to find an optimal metric and
parameter set for the DIR. For this proof-of-principle study,
two deformation metrics were used and only the number of
iterations varied. Optimization of the metrics and parameter
set may improve the results. In the current study, the results of
the evaluation methods were not always in agreement. Even
between the CT and dose values, there were some differences
due to the cumulative effect of the dose along the beam path.
The differences between change in γCT and γDose are caused
by the fact that the dose in the organs is not only dependent on
the local HU but also on the HU along the beam path. The best
evaluation method is dependent on the purpose; the evaluation
of the best parameter set should therefore always be assessed
with the correct evaluation method. In case of ART, this could
be γDose(3%,3 mm).
A limitation of an US-based deformation field is that the
volume of the CT on which one can directly calculate the
deformation field is limited to the volume of the US data
available (Fig. 3). The deformation field propagates further,
but this is not based on image data and is therefore maybe less
reliable. For patient 2, a small overlap of US volumes resulted
in a failure in parameter set E. Standardization of scanning,
so that at least the complete prostate is visible and the US
volume overlap is maximal, and US images with larger fields
of view may improve the results. Transperineal scanning with
a larger image sector or perhaps even fusion of multiple US
scans from different directions can extend the field of view.
However the US image will never completely overlap
the CT image, therefore part of the deformation field will
still be based on only an extrapolated deformation field. For
an ideal exact extrapolation, it may be crucial to take into
account the mechanical properties of tissues and organs, such
as skin, bones, and bladder, which are positioned outside of
the overlapping US images. In this work, some deformation
field propagation outside of the overlapping US volumes
is already inherently taken into account, due to the use of
the so-called multiresolution approach during the deformable
registration. In this approach, the registration starts with
images that have a lower complexity. For example, images
that were smoothed and possibly down sampled. During the
registration, a B-spline control point grid is overlaid on the
fixed image. This grid is always rectangular. Control points
that are outside of the region of interest (overlapping parts of
the US volumes) are in principle not affected. However, due
to the multiresolution approach, the control point spacing is
larger at lower resolutions than at higher resolutions. For this
reason, a larger area around the region of interest is affected
at lower resolutions, which typically produces deformations
outside of the region of interest.
Another reason why it is important to have standardization
of the US scanning is that, just like with the IGRT usage
of the US images, it is important to have reproducible US
images. In particular, the probe pressure18,32 and speed-
of-sound aberration33 along the imaging beam should be
comparable. One cannot distinguish between the US imaging
dependent changes caused by nonstandardized procedures
or a real anatomy changes. Therefore it is best to prevent
them or correct34–38 for them before the DIR procedure. For
our specific cases, preliminary inspection revealed that these
corrections were not necessary.
Validation of the DIRmethods in general is also still neces-
sary to reliably perform DIR for ART. Different deformation
algorithms lead to different results, therefore more research is
necessary.
5. CONCLUSIONS
It was possible to generate a pseudo-CTps with the use of
DIR based on US imaging which was more representative of
CTgt than CTsim. For the patients with the smaller prostate
change over time, the procedure did not improve the dose
calculations much. The largest improvements were seen for
patients with the largest anatomical changes. More research
with a larger image database is necessary to find an optimal
deformation metric and parameter set. With a larger database,
it might be possible to find a predictive measure and criteria
to decide whether DIR is worthwhile for individual patients.
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